prepulsid tab 5mg comprimé
janssen pharmaceutica, division of janssen-ortho inc. - cisapride (monohydrate de cisapride) - comprimé - 5mg - cisapride (monohydrate de cisapride) 5mg - prokinetic agents
prepulsid tab 10mg comprimé
janssen pharmaceutica, division of janssen-ortho inc. - cisapride (monohydrate de cisapride) - comprimé - 10mg - cisapride (monohydrate de cisapride) 10mg - prokinetic agents
imodium caplets 2mg comprimé
janssen pharmaceutica, division of janssen-ortho inc. - chlorhydrate de lopéramide - comprimé - 2mg - chlorhydrate de lopéramide 2mg - antidiarrhea agents
prepulsid sus 1mg/ml suspension
janssen pharmaceutica, division of janssen-ortho inc. - cisapride (monohydrate de cisapride) - suspension - 1mg - cisapride (monohydrate de cisapride) 1mg - prokinetic agents
prepulsid tab 20mg comprimé
janssen pharmaceutica, division of janssen-ortho inc. - cisapride (monohydrate de cisapride) - comprimé - 20mg - cisapride (monohydrate de cisapride) 20mg - prokinetic agents
nizoral oral suspension 20mg/ml
janssen pharmaceutica, division of janssen-ortho inc. - kétoconazole - suspension - 20mg - kétoconazole 20mg - azoles
sultrin triple sulfa crm crème
ortho pharmaceutical, division of janssen-ortho inc. - sulfathiazol; sulfacétamide; sulfanilylbenzamide; urée - crème - 3.42%; 2.86%; 3.7%; 0.64% - sulfathiazol 3.42%; sulfacétamide 2.86%; sulfanilylbenzamide 3.7%; urée 0.64% - sulfonamides
floxin i.v. liq 20mg/ml liquide
ortho pharmaceutical, division of janssen-ortho inc. - ofloxacine - liquide - 20mg - ofloxacine 20mg
jcovden (previously covid-19 vaccine janssen)
janssen-cilag international nv - adenovirus type 26 encoding the sars-cov-2 spike glycoprotein (ad26.cov2-s) - covid-19 virus infection - vaccins - jcovden is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 years of age and older. l'utilisation de ce vaccin doit être en conformité avec les recommandations officielles.
byannli (previously paliperidone janssen-cilag international)
janssen-cilag international n.v. - palmitate de palipéridone - schizophrénie - psycholeptiques - byannli (previously paliperidone janssen-cilag international) a 6 monthly injection, is indicated for the maintenance treatment of schizophrenia in adult patients who are clinically stable on 1 monthly or 3 monthly paliperidone palmitate injectable products (see section 5.